49th Annual Scientific Meeting  |  March 19-22, 2023

  
   
   

   

Industry Sponsored Symposium

Monday, March 20, 2023
7:00 am – 7:30 am

Helping to Close the Gap in Treating Female Fecal Incontinence

A vaginally inserted rectal control device (Eclipse™ System) was recently made commercially available in the US by physician prescription only.  This session will explore the vaginal insert's clinical results from the LIFE and LIBERATE Studies and implications for managing female fecal incontinence patients. 

Vaginally Inserted Bowel Control Therapy Introduction
Steve Herbowy
Former COO and co-founder of Pelvalon 

LIFE and LIBERATE Clinical Data Review and Practical Implications for Treating Women with FI
Holly E. Richter, PhD, MD, FACOG, FACS, FPMRS
University of Alabama at Birmingham, Department of Obstetrics & Gynecology
Past President of the Society of Gynecologic Surgeons (SGS)
Past President of the American Urogynecologic Society (AUGS)
Endowed Chair of the Department of Obstetrics and Gynecology at UAB
Director Research, Division of Urogynecology and Reconstructive Pelvic Surgery at UAB

Sponsored by: